Operating Income (Loss) of BIO-TECHNE Corp from 31 Mar 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
BIO-TECHNE Corp quarterly and annual Operating Income (Loss) in USD history and change rate from 31 Mar 2010 to 31 Dec 2025.
  • BIO-TECHNE Corp Operating Income (Loss) for the quarter ending 31 Dec 2025 was $54,461,000, a 15% increase year-over-year.
  • BIO-TECHNE Corp Operating Income (Loss) for the twelve months ending 31 Dec 2025 was $116,968,000, a 42% decline year-over-year.
  • BIO-TECHNE Corp annual Operating Income (Loss) for 2025 was $102,255,000, a 51% decline from 2024.
  • BIO-TECHNE Corp annual Operating Income (Loss) for 2024 was $206,686,000, a 31% decline from 2023.
  • BIO-TECHNE Corp annual Operating Income (Loss) for 2023 was $298,944,000, a 0.79% increase from 2022.
Source SEC data
View on sec.gov
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

BIO-TECHNE Corp Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $116,968,000 $54,461,000 +$7,042,000 +15% 01 Oct 2025 31 Dec 2025 10-Q 04 Feb 2026 2026 Q2
Q3 2025 $109,926,000 $47,658,000 +$7,671,000 +19% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2026 Q1
Q2 2025 $102,255,000 $23,859,000 -$69,681,000 -152% 01 Apr 2025 30 Jun 2025 10-K 22 Aug 2025 2025 FY
Q1 2025 $171,936,000 $38,708,000 -$28,290,000 -42% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q3
Q4 2024 $200,226,000 $47,419,000 +$9,415,000 +25% 01 Oct 2024 31 Dec 2024 10-Q 04 Feb 2026 2026 Q2
Q3 2024 $190,811,000 $39,987,000 -$15,875,000 -28% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2026 Q1
Q2 2024 $206,686,000 $45,822,000 -$48,703,000 -52% 01 Apr 2024 30 Jun 2024 10-K 22 Aug 2025 2025 FY
Q1 2024 $255,389,000 $66,998,000 -$13,213,000 -16% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q3
Q4 2023 $268,602,000 $38,004,000 -$29,887,000 -44% 01 Oct 2023 31 Dec 2023 10-Q 06 Feb 2025 2025 Q2
Q3 2023 $298,489,000 $55,862,000 -$455,000 -0.81% 01 Jul 2023 30 Sep 2023 10-Q 05 Nov 2024 2025 Q1
Q2 2023 $298,944,000 $94,525,000 +$13,952,000 +17% 01 Apr 2023 30 Jun 2023 10-K 22 Aug 2025 2025 FY
Q1 2023 $284,992,000 $80,211,000 -$10,236,000 -11% 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024 2024 Q3
Q4 2022 $295,228,000 $67,891,000 +$5,543,000 +8.9% 01 Oct 2022 31 Dec 2022 10-Q 07 Feb 2024 2024 Q2
Q3 2022 $289,685,000 $56,317,000 -$6,905,000 -11% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2024 Q1
Q2 2022 $296,590,000 $80,573,000 +$11,990,000 +17% 01 Apr 2022 30 Jun 2022 10-K 22 Aug 2024 2024 FY
Q1 2022 $284,600,000 $90,447,000 +$21,821,000 +32% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q3
Q4 2021 $262,779,000 $62,348,000 +$11,353,000 +22% 01 Oct 2021 31 Dec 2021 10-Q 07 Feb 2023 2023 Q2
Q3 2021 $251,426,000 $63,222,000 +$14,130,000 +29% 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022 2023 Q1
Q2 2021 $237,296,000 $68,583,000 +$29,274,000 +74% 01 Apr 2021 30 Jun 2021 10-K 23 Aug 2023 2023 FY
Q1 2021 $208,022,000 $68,626,000 +$20,835,000 +44% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q3
Q4 2020 $187,187,000 $50,995,000 +$14,003,000 +38% 01 Oct 2020 31 Dec 2020 10-Q 07 Feb 2022 2022 Q2
Q3 2020 $173,184,000 $49,092,000 +$15,765,000 +47% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021 2022 Q1
Q2 2020 $157,419,000 $39,309,000 -$3,954,000 -9.1% 01 Apr 2020 30 Jun 2020 10-K 24 Aug 2022 2022 FY
Q1 2020 $161,373,000 $47,791,000 +$3,701,000 +8.4% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021 2021 Q3
Q4 2019 $157,672,000 $36,992,000 +$3,389,000 +10% 01 Oct 2019 31 Dec 2019 10-Q 08 Feb 2021 2021 Q2
Q3 2019 $154,283,000 $33,327,000 +$7,564,000 +29% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020 2021 Q1
Q2 2019 $146,719,000 $43,263,000 +$348,000 +0.81% 01 Apr 2019 30 Jun 2019 10-K 25 Aug 2021 2021 FY
Q1 2019 $146,371,000 $44,090,000 +$1,006,000 +2.3% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q3
Q4 2018 $145,365,000 $33,603,000 +$9,455,000 +39% 01 Oct 2018 31 Dec 2018 10-Q 06 Feb 2020 2020 Q2
Q3 2018 $135,910,000 $25,763,000 -$268,000 -1% 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019 2020 Q1
Q2 2018 $136,178,000 $42,915,000 +$2,870,000 +7.2% 01 Apr 2018 30 Jun 2018 10-K 26 Aug 2020 2020 FY
Q1 2018 $133,308,000 $43,084,000 +$9,582,000 +29% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019 2019 Q3
Q4 2017 $123,726,000 $24,148,000 +$6,267,000 +35% 01 Oct 2017 31 Dec 2017 10-Q 07 Feb 2019 2019 Q2
Q3 2017 $117,459,000 $26,031,000 -$3,125,000 -11% 01 Jul 2017 30 Sep 2017 10-Q 07 Nov 2018 2019 Q1
Q2 2017 $120,584,000 $40,045,000 +$32,000 +0.08% 01 Apr 2017 30 Jun 2017 10-K/A 06 Nov 2019 2019 FY
Q1 2017 $120,552,000 $33,502,000 -$10,025,000 -23% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018 2018 Q3
Q4 2016 $130,577,000 $17,881,000 -$18,144,000 -50% 01 Oct 2016 31 Dec 2016 10-Q 08 Feb 2018 2018 Q2
Q3 2016 $148,721,000 $29,156,000 -$1,872,000 -6% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017 2018 Q1
Q2 2016 $150,593,000 $40,013,000 +$2,212,000 +5.9% 01 Apr 2016 30 Jun 2016 10-K 27 Aug 2018 2018 FY
Q1 2016 $148,381,000 $43,527,000 +$4,101,000 +10% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q3
Q4 2015 $144,280,000 $36,025,000 +$1,445,000 +4.2% 01 Oct 2015 31 Dec 2015 10-Q 09 Feb 2017 2017 Q2
Q3 2015 $142,835,000 $31,028,000 -$4,188,000 -12% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2017 Q1
Q2 2015 $147,023,000 $37,801,000 -$1,045,000 -2.7% 01 Apr 2015 30 Jun 2015 10-K 07 Sep 2017 2017 FY
Q1 2015 $148,068,000 $39,426,000 -$6,343,000 -14% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q3
Q4 2014 $154,411,000 $34,580,000 -$1,164,000 -3.3% 01 Oct 2014 31 Dec 2014 10-Q 09 Feb 2016 2016 Q2
Q3 2014 $155,575,000 $35,216,000 -$4,175,000 -11% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015 2016 Q1
Q2 2014 $159,750,000 $38,846,000 +$157,340,531 01 Apr 2014 30 Jun 2014 10-K 29 Aug 2016 2016 FY
Q1 2014 $2,409,469 $45,769,000 +$1,823,000 +4.1% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015 2015 Q3
Q4 2013 $586,469 $35,744,000 -$1,160,000 -3.1% 01 Oct 2013 31 Dec 2013 10-Q 09 Feb 2015 2015 Q2
Q3 2013 $1,746,469 $39,391,000 +$1,588,000 +4.2% 01 Jul 2013 30 Sep 2013 10-Q 10 Nov 2014 2015 Q1
Q2 2013 $158,469 $118,494,531 -$159,712,531 -387% 01 Apr 2013 30 Jun 2013 10-K 31 Aug 2015 2015 FY
Q1 2013 $159,871,000 $43,946,000 -$2,416,000 -5.2% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014 2014 Q3
Q4 2012 $162,287,000 $36,904,000 -$778,000 -2.1% 01 Oct 2012 31 Dec 2012 10-Q 04 Feb 2014 2014 Q2
Q3 2012 $163,065,000 $37,803,000 -$3,144,000 -7.7% 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013 2014 Q1
Q2 2012 $166,209,000 $41,218,000 -$1,385,000 -3.3% 01 Apr 2012 30 Jun 2012 10-K 29 Aug 2014 2014 FY
Q1 2012 $167,594,000 $46,362,000 +$1,624,000 +3.6% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013 2013 Q3
Q4 2011 $165,970,000 $37,682,000 +$331,000 +0.89% 01 Oct 2011 31 Dec 2011 10-Q 11 Feb 2013 2013 Q2
Q3 2011 $165,639,000 $40,947,000 +$2,584,000 +6.7% 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012 2013 Q1
Q2 2011 $163,055,000 $42,603,000 01 Apr 2011 30 Jun 2011 10-K 29 Aug 2013 2013 FY
Q1 2011 $44,738,000 +$3,090,000 +7.4% 01 Jan 2011 31 Mar 2011 10-Q 10 May 2012 2012 Q3
Q4 2010 $37,351,000 01 Oct 2010 31 Dec 2010 10-Q 07 Feb 2012 2012 Q2
Q3 2010 $38,363,000 01 Jul 2010 30 Sep 2010 10-Q 09 Nov 2011 2012 Q1
Q1 2010 $41,648,000 01 Jan 2010 31 Mar 2010 10-Q 10 May 2011 2011 Q3

BIO-TECHNE Corp Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $102,255,000 -$104,431,000 -51% 01 Jul 2024 30 Jun 2025 10-K 22 Aug 2025 2025 FY
2024 $206,686,000 -$92,258,000 -31% 01 Jul 2023 30 Jun 2024 10-K 22 Aug 2025 2025 FY
2023 $298,944,000 +$2,354,000 +0.79% 01 Jul 2022 30 Jun 2023 10-K 22 Aug 2025 2025 FY
2022 $296,590,000 +$59,294,000 +25% 01 Jul 2021 30 Jun 2022 10-K 22 Aug 2024 2024 FY
2021 $237,296,000 +$79,877,000 +51% 01 Jul 2020 30 Jun 2021 10-K 23 Aug 2023 2023 FY
2020 $157,419,000 +$10,700,000 +7.3% 01 Jul 2019 30 Jun 2020 10-K 24 Aug 2022 2022 FY
2019 $146,719,000 +$10,541,000 +7.7% 01 Jul 2018 30 Jun 2019 10-K 25 Aug 2021 2021 FY
2018 $136,178,000 +$15,594,000 +13% 01 Jul 2017 30 Jun 2018 10-K 26 Aug 2020 2020 FY
2017 $120,584,000 -$30,009,000 -20% 01 Jul 2016 30 Jun 2017 10-K/A 06 Nov 2019 2019 FY
2016 $150,593,000 +$3,570,000 +2.4% 01 Jul 2015 30 Jun 2016 10-K 27 Aug 2018 2018 FY
2015 $147,023,000 -$12,727,000 -8% 01 Jul 2014 30 Jun 2015 10-K 07 Sep 2017 2017 FY
2014 $159,750,000 +$159,591,531 +100708% 01 Jul 2013 30 Jun 2014 10-K 29 Aug 2016 2016 FY
2013 $158,469 -$166,050,531 -100% 01 Jul 2012 30 Jun 2013 10-K 31 Aug 2015 2015 FY
2012 $166,209,000 +$3,154,000 +1.9% 01 Jul 2011 30 Jun 2012 10-K 29 Aug 2014 2014 FY
2011 $163,055,000 +$6,727,000 +4.3% 01 Jul 2010 30 Jun 2011 10-K 29 Aug 2013 2013 FY
2010 $156,328,000 01 Jul 2009 30 Jun 2010 10-K 29 Aug 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.